Transaction details
Jeffrey P. Klenk, who serves as Executive Vice President and President of Bond & Specialty Insurance at Travelers Companies, Inc. (NYSE: TRV), completed a sale of 6,413.654 shares of the insurer's common stock on April 20, 2026. The shares were sold at a price of $305.06 per share, producing proceeds of $1,956,549. The disposition was reported to the Securities and Exchange Commission on April 21, 2026.
Following this transaction, Klenk directly owns 6,075.303 shares of Travelers common stock.
Company performance referenced in filings
The filing coincides with recent company results: Travelers reported first-quarter 2025 core income of $7.71 per share, which exceeded the consensus estimate of $7.03 per share. Separately, public reporting notes that Travelers is a roughly $64 billion insurance company and that it has increased its dividend for 20 consecutive years, according to InvestingPro.
Analyst reactions and positioning
The company's first-quarter results and outlook prompted a variety of analyst moves. Roth/MKM raised its price target on Travelers to $345 and maintained a Buy rating. BMO Capital Markets increased its price target to $314, citing a constructive earnings outlook and stating an expectation that the company’s earnings-per-share trend will exceed consensus in the next one to two years; BMO also reiterated an Outperform rating.
Evercore ISI lifted its price target to $321, calling out the potential for stock buybacks and highlighting what it described as strong underwriting performance, while noting weaker-than-expected growth in personal lines. By contrast, BofA Securities kept an Underperform rating even as it raised its price target to $276, observing that Travelers’ first-quarter results missed both its own and consensus estimates and noting negative net written premium growth in part due to the sale of a business in Canada.
Context and takeaway
The insider sale and the SEC filing provide a near-term governance data point about an executive's holdings and activity. The company-level disclosures on earnings and dividend history, together with the assortment of analyst responses - including higher price targets from several firms alongside a retained Underperform from another - reflect differing assessments of Travelers’ near-term earnings trajectory and underwriting trends.
All transaction amounts, share counts, filing dates, and analyst actions cited above are taken from the SEC filing and the company and analyst disclosures referenced in the reporting.